News | News By Subject | News by Disease News By Date | Search News

Female sexual dysfunction News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Acquisition Rumors Spread After Palatin Tech (PTN) Releases Positive Data About its Women’s Version of Viagra     11/3/2016
Sprout Team Withers as Valeant (VRX) Terminates 140 Sales Contractors for the Female Libido Drug     4/6/2016
Female Libido Drug that Valeant (VRX) Bought for $1 Billion Gets Mixed Reviews     3/1/2016
Sprout CEO Cindy Whitehead Steps Down After Bringing the Little Pink Pill to Market     12/11/2015
Female Sex Drug Addyi Not Sprouting Sales for Valeant (VRX)     11/18/2015
Sprout’s Female Libido Drug Brings Up More FDA Dissent and Men-Oriented Testing     9/17/2015
Valeant (VRX) Acquires Female Sex Drive Drug Maker Sprout for $1 Billion     8/21/2015
Sprout's First-Ever Female Libido Drug Comes With Boxed Warning and Controversy     8/20/2015
Sprout to Expand to 200 Employees After FDA Approval of Female Sex-Drive Drug     8/19/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Innovus Pharma Strikes $171.25 Million Zestra Deal With Sothema Laboratories     9/24/2014
Sprout Pharmaceuticals Eyes $15 Million From Private Investors To Develop Female Viagra     8/22/2014
FDA Wants More Info On Sprout Pharmaceuticals's Female Libido Pill     2/11/2014

News from Around the Web
The "Grassroots Campaign" For "Female Viagra" Was Actually Funded By Its Manufacturer     9/9/2016
Pain Curbs Sex Drive In Female Mice, But Not In Males, McGill University And Concordia University Study     5/1/2014
Sex And The Single Drug, Case Western Reserve University Study     6/28/2010
Viagra Helpful to Women on Antidepressants, Indiana University Study Finds     7/23/2008
Testosterone Spray Improves Sexual Satisfaction Slightly in Premenopausal Women But So Does Placebo     4/15/2008
Female G Spot Can Be Located With Ultrasound     2/22/2008
Testosterone Patch Benefits Women with Low Sexual Desire     8/15/2007
Topical Testosterone Cream Does Not Increase Sexual Drive in Female Cancer Survivors     5/2/2007
Patch 'to Boost Female Sex Drive'     3/28/2007
Labor May Not Harm Post-Pregnancy Sexual Function     9/11/2006
Pharma Companies Creating Diseases To Sell Their Medicines     4/11/2006
Rare Sexual Syndrome Needs More Research     3/24/2006
Sexual Problems Common In Women With Heart Disease     7/14/2005
No Link Found Between Low Androgen Levels And Low Sexual Function In Women     7/6/2005
Genes Affect Women's Ability To Reach Orgasm     6/8/2005

Press Releases
AMAG (AMAG) And Palatin Tech (PTN) Announce Rekynda Data Presentations At The International Society For The Study Of Women’s Sexual Health Annual Meeting     2/27/2017
TherapeuticsMD, Inc.  (TXMD) To Present Data From Phase III Rejoice Trial At Upcoming Investor & Medical Conferences     3/3/2016
Strategic Science & Technologies Initiates Phase II Study To Evaluate Topical Sildenafil In Women With Female Sexual Arousal Disorder     10/28/2015
S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) Supports FDA Approval Of First-Ever Treatment For Hypoactive Sexual Desire Disorder     8/20/2015
Sprout Receives FDA Approval of ADDYI (Flibanserin 100 MG)     8/19/2015
Apricus Biosciences (APRI) Announces It Is Seeking A Global Partner For Femprox, A Novel Treatment For Female Sexual Dysfunction     8/19/2015
Palatin Technologies (PTN) Supports FDA's Approval Of The First-Ever Treatment For Female Sexual Dysfunction     8/19/2015
FDA Panel Backs Sprout Pharmaceuticals's Female Viagra     6/5/2015
Strategic Science & Technologies Initiates Phase 1 Study To Evaluate Topical Sildenafil In Women With Female Sexual Arousal Disorder     2/9/2015
Palatin Technologies (PTN) Announces Start Of Bremelanotide Phase 3 Program For Female Sexual Dysfunction     12/29/2014
Innovus Pharma To Exhibit Zestra®, Its Clinically Proven Topical Product For Sexual Arousal And Desire At The 46th Annual Meeting Of The American Association Of Sexuality Educators Counselors & Therapists     6/5/2014
Innovus Pharma Announces The Issuance Of A New Canadian Patent For Its Zestra® Product     5/19/2014
Innovus Pharma Files For The Female Sexual Interest/Arousal Disorder (FSI/AD) Expanded Label Indication For Its Zestra® Product In Canada     5/13/2014
Innovus Pharma To Exhibit Zestra® Its Clinically Proven Product For Female Sexual Arousal And Desire At The International Society For The Study Of Women's Sexual Health 2014 Annual Meeting In San Diego     2/20/2014
Sprout Pharmaceuticals Receives Clear Guidance From FDA On Path Forward To Resubmit New Drug Application For Flibanserin, The First Potential Medical Treatment For Hypoactive Sexual Desire Disorder In Premenopausal Women     2/10/2014